Stock Taper
RxSight, Inc. develops and sells light adjustable intraocular lenses and systems that enable cataract surgeons to customize and optimize patients’ vision post-surgery.

RxSight's Light Adjustable Lens+ (LAL+) is the first customizable intraocular lens that uses light treatments to tailor vision after cataract surgery, ensuring optimized, patient-specific visual correction.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Service Warranty Service Contracts And Accessories | $1.47M | $1.46M ▼ | $1.5M ▲ | $1.4M ▼ |
![]() | L D D | $3.17M | $2.97M ▼ | $2.35M ▼ | $1.34M ▼ |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
BFLY | $8.43 | COMPARE |
KIDS | $23.65 | COMPARE |
DCTH | $16.34 | COMPARE |
CERS | $2.65 | COMPARE |
TCMD | $23.16 | COMPARE |
NPCE | $14.41 | COMPARE |
DMAC | $6.39 | COMPARE |
TMCI | $4.65 | COMPARE |